Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drug development research

Showing results (901-910 of 1,350) with videos related to

Pageof 135
Sort By:
Drug Development Research|January 27, 2025
Isoliquiritigenin Protects Against Diabetic Nephropathy in db/db Mice by Inhibiting Advanced Glycation End Product-Receptor for Advanced Glycation End Product AxisQiwen Shi, Tao Zhou, Wenjun Hou, et al.
Drug Development Research|January 20, 2025
Downregulation of LncRNA CCAT1 Enhances Chemosensitivity in Cisplatin-Resistant Gastric Cancer CellsQiong Wu, Chenglou Zhu, Tiantian Zhao, et al.
Drug Development Research|January 31, 2025
Andrographolide Mitigates Cisplatin Resistance by Inhibiting SPP1 Regulated NF-kB/iNOS/COX-2 and PI3K/AKT Pathway in Cisplatin Resistant Cervical Carcinoma CellsAkbar Pasha, Doneti Ravinder, Smita C Pawar
Drug Development Research|February 6, 2025
Design, Synthesis and Molecular Docking of New Thieno[2,3‑d]Pyrimidin-4-One Derivatives as Dual EGFR and FGFR InhibitorsSara Sultan, Samar S Tawfik, Khalid B Selim, et al.
Drug Development Research|February 10, 2025
Unraveling the Role of Repurposed Drugs in the Treatment of Acne: Success so Far and the Road AheadPopat S Kumbhar, Vikas Kamble, Kaustubh Ajit Kolekar, et al.
Drug Development Research|November 21, 2024
Design, Synthesis, and Biological Activities Evaluation of Type I FLT3 Inhibitors for the Treatment of Acute Myeloid LeukemiaJin Yang, Yan Zhang, Yue-Chu Li, et al.
Drug Development Research|December 2, 2024
Improving the Biopharmaceutical Properties of Cannabinoids in Glioblastoma Multiforme Therapy With Nanotechnology: A Drug Delivery PerspectiveStephanie B Walker, Jonatas L Duarte, Leonardo D Di Filippo, et al.
Drug Development Research|March 21, 2025
Novel Benzosuberone/Indanone-Linked Thiazoles as Small-Molecule SARS-CoV-2 Main Protease InhibitorsThoraya A Farghaly, Elham N Bifari, Mariam A Al-Sheikh, et al.
Drug Development Research|March 13, 2025
Strategies for the Discovery and Design of Tissue Plasminogen Activators: Insights Into Bioengineering ObjectivesAmirhossein Akbarpour Arsanjani, Davood Rabiei Faradonbeh, Ziba Veisi Malekshahi, et al.
Drug Development Research|October 28, 2024
Molecular docking, DFT and antiproliferative properties of 4-(3,4-dimethoxyphenyl)-3-(4-methoxyphenyl)-1-phenyl-1H-pyrazolo[3,4-b]pyridine as potent anticancer agent with CDK2 and PIM1 inhibition potencyFaizah A Binjubair, Basma S Almansour, Noha I Ziedan, et al.
Pageof 135

Showing results (901-910 of 1,350) with videos related to

Sort By:
Pageof 135
Drug Development Research|January 27, 2025
Isoliquiritigenin Protects Against Diabetic Nephropathy in db/db Mice by Inhibiting Advanced Glycation End Product-Receptor for Advanced Glycation End Product AxisQiwen Shi, Tao Zhou, Wenjun Hou, et al.
Drug Development Research|January 20, 2025
Downregulation of LncRNA CCAT1 Enhances Chemosensitivity in Cisplatin-Resistant Gastric Cancer CellsQiong Wu, Chenglou Zhu, Tiantian Zhao, et al.
Drug Development Research|January 31, 2025
Andrographolide Mitigates Cisplatin Resistance by Inhibiting SPP1 Regulated NF-kB/iNOS/COX-2 and PI3K/AKT Pathway in Cisplatin Resistant Cervical Carcinoma CellsAkbar Pasha, Doneti Ravinder, Smita C Pawar
Drug Development Research|February 6, 2025
Design, Synthesis and Molecular Docking of New Thieno[2,3‑d]Pyrimidin-4-One Derivatives as Dual EGFR and FGFR InhibitorsSara Sultan, Samar S Tawfik, Khalid B Selim, et al.
Drug Development Research|February 10, 2025
Unraveling the Role of Repurposed Drugs in the Treatment of Acne: Success so Far and the Road AheadPopat S Kumbhar, Vikas Kamble, Kaustubh Ajit Kolekar, et al.
Drug Development Research|November 21, 2024
Design, Synthesis, and Biological Activities Evaluation of Type I FLT3 Inhibitors for the Treatment of Acute Myeloid LeukemiaJin Yang, Yan Zhang, Yue-Chu Li, et al.
Drug Development Research|December 2, 2024
Improving the Biopharmaceutical Properties of Cannabinoids in Glioblastoma Multiforme Therapy With Nanotechnology: A Drug Delivery PerspectiveStephanie B Walker, Jonatas L Duarte, Leonardo D Di Filippo, et al.
Drug Development Research|March 21, 2025
Novel Benzosuberone/Indanone-Linked Thiazoles as Small-Molecule SARS-CoV-2 Main Protease InhibitorsThoraya A Farghaly, Elham N Bifari, Mariam A Al-Sheikh, et al.
Drug Development Research|March 13, 2025
Strategies for the Discovery and Design of Tissue Plasminogen Activators: Insights Into Bioengineering ObjectivesAmirhossein Akbarpour Arsanjani, Davood Rabiei Faradonbeh, Ziba Veisi Malekshahi, et al.
Drug Development Research|October 28, 2024
Molecular docking, DFT and antiproliferative properties of 4-(3,4-dimethoxyphenyl)-3-(4-methoxyphenyl)-1-phenyl-1H-pyrazolo[3,4-b]pyridine as potent anticancer agent with CDK2 and PIM1 inhibition potencyFaizah A Binjubair, Basma S Almansour, Noha I Ziedan, et al.
Pageof 135